ETC
BCYC

Exchange Traded Concepts’s Bicycle Therapeutics BCYC Stock Holding History

Exchange Traded Concepts’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,764
Closed -$108K – 1415
2025
Q1 		$108K Buy
12,764
+6,057
+90% +$71.4K ﹤0.01% 1131
2024
Q4 		$93.9K Hold
6,707
– – ﹤0.01% 1154
2024
Q3 		$152K Sell
6,707
-2,767
-29% -$63.8K ﹤0.01% 1063
2024
Q2 		$192K Sell
9,474
-2,947
-24% -$66.6K ﹤0.01% 881
2024
Q1 		$309K Buy
12,421
+5,694
+85% +$121K 0.01% 787
2023
Q4 		$122K Buy
6,727
+1,706
+34% +$28.2K ﹤0.01% 862
2023
Q3 		$101K Sell
5,021
-255
-5% -$5.83K ﹤0.01% 890
2023
Q2 		$135K Buy
+5,276
New +$123K ﹤0.01% 876

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Exchange Traded Concepts's BCYC Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Bicycle Therapeutics (BCYC) in Q2 2025, closing a stake of 12,764 shares — an estimated $108K sold.

Exchange Traded Concepts first reported a position in BCYC in Q2 2023 and held it in 8 quarters. The position peaked at $309K in Q1 2024. 110 funds tracked by Wall St. Rank hold BCYC as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Bicycle Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 12,764 Bicycle Therapeutics shares in Q2 2025, an estimated $108K.
  • Exchange Traded Concepts first reported a position in Bicycle Therapeutics in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's Bicycle Therapeutics position peaked at $309K in Q1 2024.
  • 110 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.